Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring

Cerebral Cortex

Volumn 15, Issue 12, 2005, Pages 2013-2020

  Antonelli, Tiziana ^a   Tomasini, Maria Cristina ^a   Tattoli, Maria ^b   Cassano, Tommaso ^c   Tanganelli, Sergio ^a   Finetti, Simone ^a   Mazzoni, Elisa ^a   Trabace, Luigia ^c   Steardo, Luca ^d   Cuomo, Vincenzo ^e   Ferraro, Luca ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Active avoidance behaviour; Basal and K+ evoked glutamate levels; Cortical cell cultures; Homing behaviour; Maternal marijuana consumption; Ultrasonic vocalization

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AGONIST; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POTASSIUM;

AMINO ACID BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG RECEPTOR BINDING; EMOTIONAL DEPRIVATION; EMOTIONALITY; FEMALE; FETOTOXICITY; LEARNING DISORDER; MEMORY DISORDER; NERVE CELL; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; PLACE PREFERENCE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; RAT; SEPARATION ANXIETY; SPECIES COMPARISON;

ANIMALS; ANIMALS, NEWBORN; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CEREBRAL CORTEX; CHLORATES; EMOTIONS; EXTRACELLULAR SPACE; FEMALE; GLUTAMIC ACID; MALE; MARIJUANA ABUSE; MICROTUBULE-ASSOCIATED PROTEINS; MORPHOLINES; NAPHTHALENES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, N-METHYL-D-ASPARTATE; VOCALIZATION, ANIMAL;

EID: 27744470790     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhi076     Document Type: Article

References (56)

1. Alho H, Ferrarese C, Vicini S, Vaccarino F (1988) Subsets of GABAergic neurons in dissociated cell cultures of neonatal rat cerebral cortex show co-localization with specific modulator peptides. Dev Brain Res 39:193-204.
2. Aggleton JP, Neave N, Nagle S, Sahgal A (1995) A comparison of the effects of medial prefrontal, cingulate cortex, and cingulum bundle lesions on tests of spatial memory: evidence of a double dissociation between frontal and cingulum bundle contributions. J Neurosci 15:7270-7281.
3. Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348.
4. Ang ESBC, Haydar TF, Gluncic V, Rakic P (2003) Four-dimensional migratory coordinates of GABAergic interneurons in the developing mouse cortex. J Neurosci 23:5805-5815.
5. Annau Z, Cuomo V (1988) Behavioral teratology and toxicology: a brief review. Pharmacol Res Commun 20:841-852.
6. Antonelli T, Tanganelli S, Tomasini MC, Finetti S, Trabace L, Steardo L, Sabino V, Carratu MR, Cuomo V, Ferraro L (2004) Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo [1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat. Neuroscience 124:367-375.
7. Auclair N, Otani S, Soubrie P, Crepel F (2000) Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83:3287-3293.
8. Banker G, Goslin K (1991) Culturing nerve cells. Cambridge, MA: MIT Press.
9. Bignami G (1996) Economical test methods for developmental neurobehavioral toxicity. Environ Health Perspect 104:285-298.
10. Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
11. Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72:248-254.
12. Cagiano R, Barfield RJ, White NR, Pleim ET, Weinstein M and Cuomo V (1988) Subtle behavioural changes produced in rat pups by in utero exposure to haloperidol. Eur J Pharmacol 157:45-50.
13. Cagiano R, Cassano T, Coluccia A Gaetani S, Giustino A, Steardo L, Tattoli M, Trabace L, Cuomo V (2002) Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats. Neuropsychopharmacology 26:191-203.
14. Casanova MF, Buxhoeveden DP, Switala AE, Roy E (2002) Minicolumnar pathology in autism. Neurology 58:428-432.
15. Dalterio SL (1986) Cannabinoid exposure: effects on development. Neurobehav Toxicol Teratol 8:345-352.
16. Day NL, Richardson GA, Geva D, Rubles N (1994) Alcohol, marijuana, and tobacco: effects of prenatal exposure on offspring growth and morphology at age six. Alcohol Clin Exp Res 18:786-794.
17. De Salvia MA, Cagiano R, Carratù MR, Di Giovanni, Trabace L, Cuomo V (1995) Irreversible impairment of active avoidance behavior in rats prenatally exposed to mild concentration of carbon monoxide. Psychopharmacology 122:66-71.
18. Elsner J, Suter D, Alder S (1990) Microanalysis of ultrasound vocalization of young rats. Assessment of the behavioral teratogenicity of methylmercury. Neurotoxicol Teratol 12:7-14.
19. Ferraro L, Tomasini MC, Gessa GL, Bebe BW, Tanganelli S, Antonelli T (2001) The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. Cereb Cortex 11:728-733.
20. French ED, Dillon K, Wu X (1997) Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 8:649-652.
21. Fried PA, Smith AM (2001) A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 23:1-11.
22. Garcia-Gil L, De Miguel R, Munoz RM, Cebeira M, Villanua MA, Ramos JA, Fernandez-Ruiz JJ (1997) Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats. Neurotoxicol Teratol 19:477-487.
23. Garcia-Gil L, Ramos JA, Rubino T, Parolaro D, Fernandez-Ruiz JJ (1998) Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats. Neurotoxicol Teratol 20:549-553.
24. Hampson AJ, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, Leonoudakis DJ, Bickler PE (1998) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 70:671-676.
25. Hampson RE, Deadwyler SA (1999) Cannabinoids, hippocampal function and memory. Life Sci 65:715-723.
26. Hampson RE, Deadwyler SA (2000) Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci 20:8932-8942.
27. Hernandez ML, Garcia-Gil L, Berrendero F, Ramos JA, Fernandez-Ruiz JJ (1997) Delta 9-tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons. J Mol Neurosci 8:83-91.
28. Insel TR, Hill JL, Mayor RB (1986) Rat pup ultrasonic isolation calls: possible mediation by the benzodiazepine receptor complex. Pharmacol Biochem Behav 24:1263-1267.
29. Kalant H (2004) Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 28:849-863.
30. Kathmann M, Bauer U, Schlicker E, Gothert M (1999) Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline dopamine release in the brain. Naunyn Schmiedebergs Arch Pharmacol 359:466-470.
31. Kehne JH, McCloskey TC, Baron BM, Chi EM, Harrison BL, Whitten JP, Palfreyman MG (1991) NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations. Eur J Pharmacol 193:283-292.
32. Komuro H, Rakic P (1993) Modulation of neuronal migration by NMDA receptors. Science 260:95-97.
33. Kozloski J, Hamzei-Sichani F, Yuste R (2001) Stereotyped position of local synaptic targets in neocortex. Science 293:868-872.
34. Leckman JF, Riddle MA (2000) Tourette's syndrome: when habit-forming systems form habits of their own? Neuron 28:349-354.
35. Lester BM. (1987) Developmental outcome prediction from acoustic cry analysis in term and preterm infants. Pediatrics 80:529-534.
36. Lichtman AH, Martin BR (1996) Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126:125-131.
37. Luk KC, Kennady TE, Sadikot AF (2003) Glutamate promotes proliferation of striatal neuronal progenitors by an NMDA receptor-mediated mechanism. J. Neurosci 23:2239-2255.
38. Mereu G, Fa M, Ferraro L, Cagiano R, Antonelli T, Tattoli M, Ghiglieri V, Tanganelli S, Gessa GL, Cuomo V (2003) Prenatal exposure to cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long term potentiation and glutamate release. Proc Natl Acad Sci USA 100:4915-4920.
39. Michelsson K, Sirvio P, Wasz-Hockert O (1997) Sound spectrographic cry analysis of infant with bacterial meningitis. Dev Med Child Neurol 19:309-315.
40. Misner DL, Sullivan JM (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19:6795-6805.
41. Navarro M, Rubio P, Rodriguez De Fonseca F (1995) Behavioral consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology 122:1-15.
42. 2+ signals in cerebellar granule neurons in culture. J Neurosci 19:8765-8777.
43. Palazzo E, Marabese I, de Novellis V, Oliva P, Rossi F, Berrino L, Rossi F, Maione S (2001) Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Neuropharmacology 40:319-326.
44. Parmentier-Batteur S, Jin K, Mao XO, Xie L, Greenberg DA (2002) Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci 22:9771-9775.
45. Paule MG, Bushnell PJ, Maurissen JP, Wenger GR, Buccafusco JJ, Chelonis JJ, Elliott R (1998) Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicol Teratol 20:493-502.
46. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180.
47. Pertwee RG (2000) Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opin Invest Drugs 9:1553-1571.
48. Ragozzino ME, Adams S, Kesner RP (1998) Differential involvement of the dorsal anterior cingulate and prelimbic-infralimbic areas of the rodent prefrontal cortex in spatial working memory. Behav Neurosci 112:293-303.
49. Roper SN, Eisenschenk S, King MA (1999) Reduced density of parvalbumin- and calbindin D28-immunoreactive neurons in experimental cortical dysplasia. Epilepsy Res 37:63-71.
50. Rubio P, Rodriguez de Fonseca F, Martin-Calderon JL, Del Arco I, Bartolome S, Villanua MA, Navarro M. (1998) Maternal exposure to low doses of delta9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring. Pharmacol Biochem Behav 61:229-238.
51. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic neurotransmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
52. Smith AM, Fried PA, Hogan MJ, Cameron J (2004) Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol Teratol 26:533-542.
53. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778.
54. Sullivan JM (1999) Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J Neurophysiol 82:1286-1294.
55. Terranova JP, Michaud JC, Le Fur G, Soubrie P (1995) Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Pharmacol 352:576-579.
56. Vela G, Martin S, Garcia-Gil L, Crespo JA, Ruiz-Gayo M, Javier Fernandez-Ruiz J, Garcia-Lecumberri C, Pelaprat D, Fuentes JA, Ramos JA, Ambrosio E (1998) Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Res 807:101-109.